Cargando…

Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction

Cardiovascular diseases are the leading cause of mortality in the world. Heart failure with preserved ejection fraction (HFpEF) accounts for about half of all heart failure. Unfortunately, the mechanisms of HFpEF are still unclear, leading to little progress of effective treatment of HFpEF. Arterial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Chen, Liu, Yifan, Xu, Yawei, Xu, Dachun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385653/ https://www.ncbi.nlm.nih.gov/pubmed/34458336 http://dx.doi.org/10.3389/fcvm.2021.707162

Ejemplares similares

Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
por: Ma, Teng, et al.
Publicado: (2021)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure
por: Zhang, Junyi, et al.
Publicado: (2021)

Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2019)

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
por: Graziani, Francesca, et al.
Publicado: (2021)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
por: Zhu, Kaiyuan, et al.
Publicado: (2021)

Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
por: Matan, Dmitri, et al.
Publicado: (2022)

Prognostic relevance of left atrial function and stiffness in heart failure with preserved ejection fraction patients with and without diabetes mellitus
por: Zhu, Shuangshuang, et al.
Publicado: (2022)

Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction
por: Li, Yi, et al.
Publicado: (2021)

Initial Invasive or Conservative Strategy in Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease
por: Gu, Jun, et al.
Publicado: (2022)

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
por: Huang, Peisen, et al.
Publicado: (2021)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
por: Abramov, Dmitry, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction—Out with the old and out with the new?
por: Tolento Cortes, Luis, et al.
Publicado: (2022)

Skeletal muscle phenotypic switching in heart failure with preserved ejection fraction
por: Saw, Eng Leng, et al.
Publicado: (2022)

Sympathetic and hemodynamic responses to exercise in heart failure with preserved ejection fraction
por: Manabe, Kazumasa, et al.
Publicado: (2023)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction
por: Zhang, Beijian, et al.
Publicado: (2021)

Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
por: Kuo, Jen-Yuan, et al.
Publicado: (2022)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
por: Ajmal, Maryam, et al.
Publicado: (2021)

Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
por: Huang, Ziyin, et al.
Publicado: (2022)

Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction
por: Del Torto, Alberico, et al.
Publicado: (2022)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
por: Valero-Muñoz, María, et al.
Publicado: (2022)

C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
por: Park, Jin Joo, et al.
Publicado: (2022)

Estimated Glomerular Filtration Rate Is Associated With an Increased Risk of Death in Heart Failure Patients With Preserved Ejection Fraction
por: Chen, Zhuo, et al.
Publicado: (2021)

Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
por: Oh, Albin, et al.
Publicado: (2019)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction
por: Sun, Yuxi, et al.
Publicado: (2021)

A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities
por: Hubesch, Géraldine, et al.
Publicado: (2022)

“Obesity–Years” Burden May Predict Reversibility in Heart Failure With Preserved Ejection Fraction
por: Chockalingam, Anand
Publicado: (2022)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
por: Lau, Clement, et al.
Publicado: (2022)

In vitro benchtop mock circulatory loop for heart failure with preserved ejection fraction emulation
por: Malone, Andrew, et al.
Publicado: (2022)

Overcoming the Limits of Ejection Fraction and Ventricular-Arterial Coupling in Heart Failure
por: Antohi, Elena-Laura, et al.
Publicado: (2022)

Triglyceride-glucose index for the detection of subclinical heart failure with preserved ejection fraction in patients with type 2 diabetes
por: Wang, Tingting, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design
por: Ali, Danish, et al.
Publicado: (2019)

High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
por: Bai, Bo, et al.
Publicado: (2021)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Different Pathophysiology and Outcomes of Heart Failure With Preserved Ejection Fraction Stratified by K-Means Clustering
por: Harada, Daisuke, et al.
Publicado: (2020)

Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction
por: Jiang, Jing, et al.
Publicado: (2022)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4j2gr5dqtiodlr88j1gjp5sinl